TRIESENCE
Peaktriamcinolone acetonide
NDAINTRAVITREALINJECTABLEPriority Review
Approved
Nov 2007
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
8
Mechanism of Action
Corticosteroid Hormone Receptor Agonists
Pharmacologic Class:
Corticosteroid
Clinical Trials (5)
Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy Volunteers
Started Oct 2020
Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide
Started Nov 2014
4 enrolled
CYSTOID MACULAR EDEMA
Will the Use of Triesence During Glaucoma Surgery Provide Lower Eye Pressure and Improve the Results of the Surgery?
Started Feb 2009
77 enrolled
Glaucoma
Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR)
Started Mar 2007
299 enrolled
Rhinitis, Allergic, Perennial
Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema
Started Jul 2006
60 enrolled
Diabetic RetinopathyDiabetic Macular Edema
Loss of Exclusivity
LOE Date
Dec 17, 2029
46 months away
Patent Expiry
Dec 17, 2029